Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 58408-58409 [2010-24006]

Download as PDF 58408 Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices unless the Part D appeals rules provide otherwise, the Part C appeals rules (including the annually adjusted AIC threshold amount) apply to Part D appeals to the extent they are appropriate. More specifically, § 423.1970 and § 423.1976 of the Part D appeals rules discuss the AIC threshold amounts for ALJ hearings and judicial review. Section 423.1970(a) grants a Part D enrollee, who is dissatisfied with the Independent Review Entity (IRE) reconsideration determination, a right to an ALJ hearing if the amount remaining in controversy after the IRE reconsideration meets the threshold amount established annually by the Secretary. Sections 423.1976(a) and (b) allow a Part D enrollee to request judicial review of an ALJ or MAC decision if, in part, the AIC meets the threshold amount established annually by the Secretary. II. Annual AIC Adjustments A. AIC Adjustment Formula and AIC Adjustments As previously noted, section 940 of the MMA requires that the AIC threshold amounts be adjusted annually, beginning in January 2005, by the percentage increase in the medical care component of the consumer price index (CPI) for all urban consumers (U.S. city average) for July 2003 to the July of the preceding year involved and rounded to the nearest multiple of $10. B. Calendar Year 2011 The AIC threshold amount for ALJ hearing requests will remain at $130 and the AIC threshold amount for judicial review will rise to $1,300 for the 2011 calendar year. These updated amounts are based on the 30.34 percent increase in the medical care component of the CPI from July of 2003 to July of 2010. The CPI level was at 297.6 in July of 2003 and rose to 387.898 in July of 2010. This change accounted for the 30.34 percent increase. The AIC threshold amount for ALJ hearing requests changes to $130.34 based on the 30.34 percent increase. In accordance with section 940 of the MMA, this amount is rounded to the nearest multiple of $10. Therefore, the 2011 AIC threshold amount for ALJ hearings is $130. The AIC threshold amount for judicial review changes to $1,303.42 based on the 30.34 percent increase. This amount was rounded to the nearest multiple of $10, resulting in a 2011 AIC threshold amount of $1,300. C. Summary Table of Adjustments in the AIC Threshold Amounts In Table 1 below, we list the (CY) 2005 through 2011 threshold amounts. TABLE 1—AMOUNT-IN-CONTROVERSY THRESHOLD AMOUNTS CY 2005 CY 2006 CY 2007 CY 2008 CY 2009 CY 2010 CY 2011 $100 1,050 $110 1,090 $110 1,130 $120 1,180 $120 1,220 $130 1,260 $130 1,300 ALJ Hearing ......................................................................... Judicial Review .................................................................... * CY—Calendar Year. III. Collection of Information Requirements DEPARTMENT OF HEALTH AND HUMAN SERVICES This document does not impose information collection and recordkeeping requirements. Consequently, it need not be reviewed by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 35). Centers for Disease Control and Prevention (Catalog of Federal Domestic Assistance Program No. 93.778, Medical Assistance Program; No. 93.773 Medicare—Hospital Insurance Program; and No. 93.774, Medicare—Supplementary Medical Insurance Program) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned subcommittee: Time and Date: 9 a.m.–5 p.m., October 13, 2010. Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, Kentucky 41018. Telephone (859) 334–4611, Fax (859) 334–4619. Status: Open to the public, but without a public comment period. To access by conference call, dial the following information: (866) 659–0537, Participant Pass Code 9933701. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the compensation program. Key functions of Dated: September 2, 2010. Donald M. Berwick, Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2010–23584 Filed 9–23–10; 8:45 am] srobinson on DSKHWCL6B1PROD with NOTICES BILLING CODE 4120–01–P VerDate Mar<15>2010 16:12 Sep 23, 2010 Jkt 220001 Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 the ABRWH include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the ABRWH to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2011. Purpose: The ABRWH is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation E:\FR\FM\24SEN1.SGM 24SEN1 srobinson on DSKHWCL6B1PROD with NOTICES Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices but for whom it is not feasible to estimate their radiation dose, and on whether there is a reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee on Procedures Review was established to aid the ABRWH in carrying out its duty to advise the Secretary, HHS, on dose reconstructions. The Subcommittee on Procedures Review is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor. Matters To Be Discussed: The agenda for the Subcommittee meeting includes: Review of draft prototype documents for informing the public on completed Subcommittee procedure reviews; discussion of the following ORAU & OCAS procedures: PER–012 (‘‘Evaluation of Highly Insoluble Plutonium Compounds’’), PER–009 (‘‘Target Organs for Lymphoma’’), OCAS TIB–0013 (‘‘Special External Dose Reconstruction Considerations for Mallinckrodt Workers’’), OTIB–014 (‘‘Rocky Flats Internal Dosimetry CoWorker Extension’’), OTIB–019 (‘‘Analysis of Co-worker Bioassay Data for Internal Dose Assignment’’), OTIB– 0029 (‘‘Internal Dosimetry Co-worker Data for Y–12’’), OTIB–0049 (‘‘Estimating Doses for Plutonium Strongly Retained in the Lung’’), OTIB– 0047 (External Radiation Monitoring at the Y–12 Facility During the 1948–1949 Period’’), OTIB–0051 (‘‘Effect of Threshold Energy and Angular Response of NTA Film on Missed Neutron Dose at the Oak Ridge Y–12 Facility’’), OTIB–0052 (‘‘Parameters to Consider When Processing Claims for Construction Trade Workers’’), OTIB– 0054 (‘‘Fission and Activation Product Assignment for Internal Dose-Related Gross Beta and Gross Gamma Analyses’’), OTIB–0057 (‘‘External Radiation Dose Estimates For Individuals Near the 1958 Criticality Accident at the Oak Ridge Y–12 Plant’’), OTIB–0070 (‘‘Dose Reconstruction During Residual Radioactivity Periods at Atomic Weapons Employer Facilities’’), and TBD 6000 (‘‘Site Profile for Atomic Weapons Employers that Worked Uranium and Thorium Metals’’); and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. This meeting is open to the public, but without a public comment period. In the event an individual wishes to VerDate Mar<15>2010 16:12 Sep 23, 2010 Jkt 220001 provide comments, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below in advance of the meeting. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30333, Telephone (513) 533–6800, Toll Free 1 (800) CDC–INFO, E-mail dcas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 17, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. 58409 Blvd., Rm. 676, Bethesda, MD 20892–4878, 301–594–4861, mooremar@nidcr.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; RFA DE–11–001 Collaborative Research on the Transition From Acute to Chronic Pain: New Models and Measures in Clinical and Preclinical Pain Research (R01). Date: October 28, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Hotel—Silver Spring, 8777 Georgia Avenue, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Victor Henriquez, PhD, Scientific Review Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 20892–4878, 301–451–2405, henriquv@nidcr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) [FR Doc. 2010–24006 Filed 9–23–10; 8:45 am] Dated: September 20, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4163–18–P [FR Doc. 2010–23951 Filed 9–23–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Scientific Review of P01 Applications submitted to PAR 08–117. Date: October 20, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Marilyn Moore-Hoon, PhD, Scientific Review Officer, Scientific Review Branch, National Institute of Dental and Craniofacial Research, 6701 Democracy PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review F30s, R03. Date: October 18, 2010. Time: 2:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mary Kelly, Scientific Review Officer, Scientific Review Branch, E:\FR\FM\24SEN1.SGM 24SEN1

Agencies

[Federal Register Volume 75, Number 185 (Friday, September 24, 2010)]
[Notices]
[Pages 58408-58409]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24006]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Subcommittee on Procedures Review, Advisory Board on Radiation 
and Worker Health (ABRWH), National Institute for Occupational Safety 
and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
subcommittee:
    Time and Date: 9 a.m.-5 p.m., October 13, 2010.
    Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, 
Kentucky 41018. Telephone (859) 334-4611, Fax (859) 334-4619.
    Status: Open to the public, but without a public comment period. To 
access by conference call, dial the following information: (866) 659-
0537, Participant Pass Code 9933701.
    Background: The ABRWH was established under the Energy Employees 
Occupational Illness Compensation Program Act of 2000 to advise the 
President on a variety of policy and technical functions required to 
implement and effectively manage the compensation program. Key 
functions of the ABRWH include providing advice on the development of 
probability of causation guidelines that have been promulgated by the 
Department of Health and Human Services (HHS) as a final rule; advice 
on methods of dose reconstruction which have also been promulgated by 
HHS as a final rule; advice on the scientific validity and quality of 
dose estimation and reconstruction efforts being performed for purposes 
of the compensation program; and advice on petitions to add classes of 
workers to the Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the ABRWH to HHS, which subsequently 
delegated this authority to CDC. NIOSH implements this responsibility 
for CDC. The charter was issued on August 3, 2001, renewed at 
appropriate intervals, and will expire on August 3, 2011.
    Purpose: The ABRWH is charged with (a) providing advice to the 
Secretary, HHS, on the development of guidelines under Executive Order 
13179; (b) providing advice to the Secretary, HHS, on the scientific 
validity and quality of dose reconstruction efforts performed for this 
program; and (c) upon request by the Secretary, HHS, advising the 
Secretary on whether there is a class of employees at any Department of 
Energy facility who were exposed to radiation

[[Page 58409]]

but for whom it is not feasible to estimate their radiation dose, and 
on whether there is a reasonable likelihood that such radiation doses 
may have endangered the health of members of this class. The 
Subcommittee on Procedures Review was established to aid the ABRWH in 
carrying out its duty to advise the Secretary, HHS, on dose 
reconstructions. The Subcommittee on Procedures Review is responsible 
for overseeing, tracking, and participating in the reviews of all 
procedures used in the dose reconstruction process by the NIOSH 
Division of Compensation Analysis and Support (DCAS) and its dose 
reconstruction contractor.
    Matters To Be Discussed: The agenda for the Subcommittee meeting 
includes: Review of draft prototype documents for informing the public 
on completed Subcommittee procedure reviews; discussion of the 
following ORAU & OCAS procedures: PER-012 (``Evaluation of Highly 
Insoluble Plutonium Compounds''), PER-009 (``Target Organs for 
Lymphoma''), OCAS TIB-0013 (``Special External Dose Reconstruction 
Considerations for Mallinckrodt Workers''), OTIB-014 (``Rocky Flats 
Internal Dosimetry Co-Worker Extension''), OTIB-019 (``Analysis of Co-
worker Bioassay Data for Internal Dose Assignment''), OTIB-0029 
(``Internal Dosimetry Co-worker Data for Y-12''), OTIB-0049 
(``Estimating Doses for Plutonium Strongly Retained in the Lung''), 
OTIB-0047 (External Radiation Monitoring at the Y-12 Facility During 
the 1948-1949 Period''), OTIB-0051 (``Effect of Threshold Energy and 
Angular Response of NTA Film on Missed Neutron Dose at the Oak Ridge Y-
12 Facility''), OTIB-0052 (``Parameters to Consider When Processing 
Claims for Construction Trade Workers''), OTIB-0054 (``Fission and 
Activation Product Assignment for Internal Dose-Related Gross Beta and 
Gross Gamma Analyses''), OTIB-0057 (``External Radiation Dose Estimates 
For Individuals Near the 1958 Criticality Accident at the Oak Ridge Y-
12 Plant''), OTIB-0070 (``Dose Reconstruction During Residual 
Radioactivity Periods at Atomic Weapons Employer Facilities''), and TBD 
6000 (``Site Profile for Atomic Weapons Employers that Worked Uranium 
and Thorium Metals''); and a continuation of the comment-resolution 
process for other dose reconstruction procedures under review by the 
Subcommittee.
    The agenda is subject to change as priorities dictate.
    This meeting is open to the public, but without a public comment 
period. In the event an individual wishes to provide comments, written 
comments may be submitted. Any written comments received will be 
provided at the meeting and should be submitted to the contact person 
below in advance of the meeting.
    Contact Person for More Information: Theodore Katz, Designated 
Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, 
Georgia 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, E-
mail dcas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: September 17, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-24006 Filed 9-23-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.